Red Arrow Therapeutics
About:
Red Arrow Therapeutics is a biotech firm that provides systemic cytokine delivery, targeted intratumoral activation, and biological potency.
Website: https://redarrowtx.com
Top Investors: Beyond Next Ventures, UTEC - The University of Tokyo Edge Capital Partners, Osaka University Venture Capital, MassChallenge, Keio Innovation Initiative
Description:
Total Funding Amount:
700M JPY
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Tokyo, Tokyo, Japan
Founded Date:
2021-08-19
Founders:
Takuya Miyazaki
Number of Employees:
1-10
Last Funding Date:
2024-04-23
IPO Status:
Private
Industries:
© 2025 bioDAO.ai